Showing 1 - 10 of 652
distinction seems to emerge. On the one hand, systems that rely on market-based competition in pharmaceuticals promote a clear …
Persistent link: https://www.econbiz.de/10005034975
This paper develops a model of pricing and advertising in a matching environment with capacity constrained sellers and …. Equilibrium prices and profit maximizing advertising levels are derived and their properties analyzed. The model generates an … inverted U-shape relationship between individual advertisement and market tightness which is robust to alternative advertising …
Persistent link: https://www.econbiz.de/10008680300
A fundamental question in pharmaceutical marketing management is: How does the effectiveness of detailing change when additional information on drugs is revealed via patients' experiences during the product lifecycle? To address this question, we develop a model of detailing and prescribing...
Persistent link: https://www.econbiz.de/10005787016
This paper investigates whether aggregate consumer learning together with consumer heterogeneity in price sensitivity could explain why (i) there is a slow diffusion of generic drugs into the market, and (ii) brand-name originators keep increasing their prices over time even after the number of...
Persistent link: https://www.econbiz.de/10005622024
A substantial number of studies have extended the work on universal properties in physical systems to complex networks in social, biological, and technological systems. In this paper, we present a complex networks perspective on interfirm organizational networks by mapping, analyzing and...
Persistent link: https://www.econbiz.de/10009211228
We study the exit of hospitals from the market for inpatient services. More generous hospital reimbursement significantly reduces the probability of exit throughout the 1990s. Conditional on reimbursement levels, hospital efficiency was not a significant determinant in the early 1990s but in the...
Persistent link: https://www.econbiz.de/10008642677
Within the debate about the rise of costs in the German health system, the argument has put forth that patients' excessive demand for benefits is caused by the existence of a moral hazard problem. One way of influencing an insured person's consumer behaviour is the introduction of several...
Persistent link: https://www.econbiz.de/10008765092
expenditure is of course influenced by policy and also by problems and inefficiencies on the market for pharmaceuticals production …
Persistent link: https://www.econbiz.de/10011114476
We analyze the influence of technological progress on pharmaceuticals on rising health expenditures using US State …
Persistent link: https://www.econbiz.de/10005790100
choice - (local) social interactions and (global) advertising - interact. We study the general behavior of the models using … market. For one of the models criticality is observed - below a certain critical level of advertising the market approaches a …
Persistent link: https://www.econbiz.de/10005790235